Zum Hauptinhalt springen

Hepatitiden

24. Januar 2018 | Hepatitiden

Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?.

Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?. Christensen, S., Buggisch, P., Mauss, S., Böker, K. H. W., Schott, E., Klinker, H., Zimmermann, T., Weber…

24. Januar 2018 | Hepatitiden

Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.

Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Bregenzer A, Conen A, Knuchel J, Friedl A, Eigenmann F, Näf M, Ackle P, Rot…

24. Januar 2018 | Hepatitiden

Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.

Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study. Robaeys G, Christensen S, Lucidarme D, Arain A, Bruggmann P, Kunkel J, Keim S, Jäkel M, DeMasi R, Liu C, Lonjon-…

24. Januar 2018 | Hepatitiden

Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection.

Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection. Dickson-Spillmann M, Haug S, Uchtenhagen A, Bruggmann P, Schaub MP. Eur Addict Res. 2016;22(4):18…

17. Januar 2018 | Hepatitiden

Wenig Studien zum Nutzen neuer Hepatitis-C-Therapie bei Jugendlichen

Wenig Studien zum Nutzen neuer Hepatitis-C-Therapie bei Jugendlichen Köln/Berlin – Jugendliche mit einer vorbehandelten Hepatitis-C-Infektion des Genotyps 2 oder 3 könnten von einer Kombinationstherapie aus dem NS5B-Inhibitor Sofosb…

17. Januar 2018 | Hepatitiden

Best Practice Testing Failed to ID Hidden HCV Infections

Best Practice Testing Failed to ID Hidden HCV Infections A best practices strategy to improve detection of hepatitis B (HBV) and HCV virus infections had high uptake but failed to find undiagnosed HCV infections, a study found. (Veronica Hackethal…

15. Januar 2018 | Hepatitiden

Hepatitis C Testing in the Community

Hepatitis C Testing in the Community (CORRELATION network, Amsterdam, 2018) http://www.hcvcommunitytesting.info/wp-content/uploads/2017/12/hcv_testing_web.pdf

Weitere
akutelle Informationen
zu den Themengebieten